Robert B. Levy

5.1k total citations
160 papers, 4.0k citations indexed

About

Robert B. Levy is a scholar working on Immunology, Hematology and Molecular Biology. According to data from OpenAlex, Robert B. Levy has authored 160 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 109 papers in Immunology, 62 papers in Hematology and 21 papers in Molecular Biology. Recurrent topics in Robert B. Levy's work include T-cell and B-cell Immunology (71 papers), Immune Cell Function and Interaction (65 papers) and Hematopoietic Stem Cell Transplantation (61 papers). Robert B. Levy is often cited by papers focused on T-cell and B-cell Immunology (71 papers), Immune Cell Function and Interaction (65 papers) and Hematopoietic Stem Cell Transplantation (61 papers). Robert B. Levy collaborates with scholars based in United States, France and Japan. Robert B. Levy's co-authors include Alex D. Reyes, James L.M. Ferrara, Eckhard R. Podack, Nelson J. Chao, Alan M. Hanash, Chiye Aoki, Thomas R. Malek, Norman H. Altman, E R Podack and Noriaki Tokuda and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Clinical Investigation.

In The Last Decade

Robert B. Levy

150 papers receiving 3.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert B. Levy United States 33 2.3k 1.4k 772 507 380 160 4.0k
Abdelali Jalil France 26 1.3k 0.5× 406 0.3× 1.1k 1.5× 602 1.2× 237 0.6× 48 3.1k
Martin S. Weber Germany 41 2.6k 1.1× 253 0.2× 967 1.3× 875 1.7× 222 0.6× 150 5.4k
Tomoko Hara Japan 24 637 0.3× 326 0.2× 1.1k 1.4× 313 0.6× 444 1.2× 75 2.5k
Shengli Xu Singapore 28 2.0k 0.9× 212 0.1× 996 1.3× 363 0.7× 156 0.4× 79 3.5k
Megumu Ogawa Japan 32 1.2k 0.5× 863 0.6× 2.6k 3.4× 635 1.3× 405 1.1× 71 4.6k
Burkhart Schraven Germany 49 4.3k 1.8× 478 0.3× 3.2k 4.2× 1.3k 2.5× 329 0.9× 200 7.7k
Ted Yednock United States 38 2.3k 1.0× 554 0.4× 1.9k 2.4× 1.0k 2.1× 408 1.1× 78 5.9k
Guillermo Izquierdo Spain 29 803 0.3× 319 0.2× 1.4k 1.8× 698 1.4× 79 0.2× 131 4.1k
Brigitte Wildemann Germany 49 2.0k 0.9× 249 0.2× 1.4k 1.8× 662 1.3× 671 1.8× 213 9.8k
Alfred Sandrock United States 30 1.6k 0.7× 472 0.3× 1.3k 1.6× 3.0k 5.8× 640 1.7× 59 8.3k

Countries citing papers authored by Robert B. Levy

Since Specialization
Citations

This map shows the geographic impact of Robert B. Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert B. Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert B. Levy more than expected).

Fields of papers citing papers by Robert B. Levy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert B. Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert B. Levy. The network helps show where Robert B. Levy may publish in the future.

Co-authorship network of co-authors of Robert B. Levy

This figure shows the co-authorship network connecting the top 25 collaborators of Robert B. Levy. A scholar is included among the top collaborators of Robert B. Levy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert B. Levy. Robert B. Levy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ding, Ying, Aixin Yu, Sabrina Copsel, et al.. (2025). BLIMP-1 and CEACAM1 cooperatively regulate human Treg homeostasis and function to control xenogeneic GVHD. JCI Insight. 10(20).
2.
Copsel, Sabrina, Brent Pfeiffer, Dietlinde Wolf, et al.. (2025). Pretransplant targeting of TNFRSF25 and CD25 stimulates recipient Tregs in target tissues, ameliorating GVHD post-HSCT. Blood. 146(22). 2710–2727.
3.
Copsel, Sabrina, Vanessa T. Garrido, Brent Pfeiffer, et al.. (2024). Minnelide suppresses GVHD and enhances survival while maintaining GVT responses. JCI Insight. 9(9). 2 indexed citations
4.
Copsel, Sabrina, Ying Ding, Dietlinde Wolf, et al.. (2023). Regulatory T Cell Amelioration of Graft-versus-Host Disease following Allogeneic/Xenogeneic Hematopoietic Stem Cell Transplantation Using Mobilized Mouse and Human Peripheral Blood Donors. Transplantation and Cellular Therapy. 29(5). 341.e1–341.e9. 4 indexed citations
5.
Wolf, Dietlinde, et al.. (2022). Recipient Pre-HSCT Treatment with TNFRSF25 and CD25 Agonists Ameliorates Gvhd in a Host Treg Dependent Manner Following Murine MHC-Mismatched Transplantation. Transplantation and Cellular Therapy. 28(3). S276–S277. 1 indexed citations
6.
Copsel, Sabrina, et al.. (2022). Recipient Tregs: Can They Be Exploited for Successful Hematopoietic Stem Cell Transplant Outcomes?. Frontiers in Immunology. 13. 932527–932527. 4 indexed citations
7.
Levy, Robert B., et al.. (2021). Understanding Immune Responses to Surgical Transplant Procedures in Stevens Johnsons Syndrome Patients. Frontiers in Medicine. 8. 656998–656998. 3 indexed citations
8.
Copsel, Sabrina, Thomas R. Malek, & Robert B. Levy. (2020). Medical Treatment Can Unintentionally Alter the Regulatory T-Cell Compartment in Patients with Widespread Pathophysiologic Conditions. American Journal Of Pathology. 190(10). 2000–2012. 6 indexed citations
10.
Tan, Yu‐zhen, Midhat H. Abdulreda, Fernando Cruz‐Guilloty, et al.. (2013). Role of T Cell Recruitment and Chemokine-Regulated Intra-Graft T Cell Motility Patterns in Corneal Allograft Rejection. American Journal of Transplantation. 13(6). 1461–1473. 26 indexed citations
11.
Ogiwara, Hideki, Irene Helenowski, Maryanne H. Marymont, et al.. (2012). Intracranial relapse rates and patterns, and survival trends following post-resection cavity radiosurgery for patients with single intracranial metastases. Journal of Neuro-Oncology. 108(1). 141–146. 21 indexed citations
13.
Adeegbe, Dennis O., Robert B. Levy, & Thomas R. Malek. (2007). Adoptive therapy with allogeneic CD4+CD25+ Foxp3+ Treg cells induces transplantation tolerance (102.10). The Journal of Immunology. 178(1_Supplement). S206–S206.
14.
15.
Adeegbe, Dennis O., Allison L. Bayer, Robert B. Levy, & Thomas R. Malek. (2006). Cutting Edge: Allogeneic CD4+CD25+Foxp3+ T Regulatory Cells Suppress Autoimmunity while Establishing Transplantation Tolerance. The Journal of Immunology. 176(12). 7149–7153. 62 indexed citations
16.
Komatsu, Masanobu, Michele Mammolenti, Monica Jones, et al.. (2003). Antigen-primed CD8+ T cells can mediate resistance, preventing allogeneic marrow engraftment in the simultaneous absence of perforin-, CD95L-, TNFR1-, and TRAIL-dependent killing. Blood. 101(10). 3991–3999. 27 indexed citations
17.
Yu, Aixin, Jiehao Zhou, Norman W. Marten, et al.. (2003). Efficient Induction of Primary and Secondary T Cell-Dependent Immune Responses In Vivo in the Absence of Functional IL-2 and IL-15 Receptors. The Journal of Immunology. 170(1). 236–242. 50 indexed citations
18.
Levy, Robert B., Adrian Cotterell, Martinque K. Jones, & Thomas R. Malek. (1988). Graft-versus-host reaction-induced immune modulation. I. Donor-recipient genetic disparity and the differential expression of Lyt-2, L3T4, and Ly-6 during acute reactions in the host thymus.. The Journal of Immunology. 140(6). 1717–1725. 7 indexed citations
20.
Biddison, William E., Ted H. Hansen, Robert B. Levy, & Peter C. Doherty. (1978). Involvement of H-2L gene products in virus-immune T-cell recognition. Evidence for an H-2L-restricted T-cell response.. The Journal of Experimental Medicine. 148(6). 1678–1686. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026